Provided by Tiger Fintech (Singapore) Pte. Ltd.

Benitec Biopharma

13.63
+0.04000.29%
Volume:7.03K
Turnover:95.02K
Market Cap:347.49M
PE:-7.04
High:13.82
Open:13.20
Low:13.16
Close:13.59
Loading ...

Company Profile

Company Name:
Benitec Biopharma
Exchange:
NASDAQ
Establishment Date:
1995
Employees:
16
Office Location:
3940 Trust Way,Hayward,California,United States
Zip Code:
94545
Fax:
- -
Introduction:
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.

Directors

Name
Position
Jerel A. Banks
Chief Executive Officer, Chairman of the Board
Megan Boston
Executive Director, Director
Edward Smith
Director
J. Kevin Buchi
Director
Peter Francis
Director

Shareholders

Name
Position
Jerel A. Banks
Chief Executive Officer, Chairman of the Board
Megan Boston
Executive Director, Director